Influence of Acarbose on Plasma Glucose Fluctuations in Insulin-Treated Patients with Type 2 Diabetes: A Pilot Study
Background and Aims. To evaluate the effect of adding acarbose on glycemic excursions measured by continuous glucose monitoring system (CGMS) in patients with type 2 diabetes mellitus (T2DM) already on insulin therapy. Materials and Methods. This was an opened and unblended study. 134 patients with...
Main Authors: | Li, Feng-fei, Xu, Xiao-hua, Fu, Li-yuan, Su, Xiao-fei, Wu, Jin-dan, Lu, Chun-feng, Ye, Lei, Ma, Jian-hua |
---|---|
Format: | Online |
Language: | English |
Published: |
Hindawi Publishing Corporation
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658413/ |
Similar Items
-
Blood Glucose Fluctuations in Type 2 Diabetes Patients Treated with Multiple Daily Injections
by: Li, Feng-fei, et al.
Published: (2016) -
Effects of saxagliptin add-on therapy to insulin on blood glycemic fluctuations in patients with type 2 diabetes: A randomized, control, open-labeled trial
by: Li, Feng-fei, et al.
Published: (2016) -
Acarbose Reduces Blood Glucose by Activating miR-10a-5p and miR-664 in Diabetic Rats
by: Zhang, Qian, et al.
Published: (2013) -
Safety and efficacy of acarbose in the treatment of diabetes in Chinese patients
by: He, Ke, et al.
Published: (2014) -
Combined use of basal insulin analog and acarbose reduces postprandial glucose in patients with uncontrolled type 2 diabetes
by: Kim, Ji-Hyun, et al.
Published: (2015)